Early research (Phase 1)Study completedNCT00452257What this trial is testingEnzastaurin in Patients With LeukemiaWho this might be right forLeukemia, Lymphocytic Eli Lilly and Company 18
Not applicableNot Yet RecruitingNCT07710781What this trial is testingStudy to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic MalignanciesWho this might be right forHematologic MalignancyAcute LeukemiaAcute Lymphoblastic Leukemia+9 more Ossium Health, Inc. 300
Testing effectiveness (Phase 2)UnknownNCT04271800What this trial is testingSafety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and LymphomaWho this might be right forLeukemiaLymphomaLeukemia, B-Cell+1 more Chongqing Precision Biotech Co., Ltd 40
Testing effectiveness (Phase 2)Ended earlyNCT01116232What this trial is testingSirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00274963What this trial is testingBendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia German CLL Study Group 60
Large-scale testing (Phase 3)Looking for participantsNCT06846671What this trial is testingTacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) InhibitorsWho this might be right forCLLChronic Lymphocytic Leukemia BeOne Medicines 250
Early research (Phase 1)Study completedNCT00891072What this trial is testingGossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaContiguous Stage II Adult Burkitt Lymphoma+78 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT02251548What this trial is testingA Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaLeukemia Dana-Farber Cancer Institute 85
Testing effectiveness (Phase 2)Study completedNCT01515176What this trial is testingOfatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+1 more National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Ended earlyNCT00748189What this trial is testingOfatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic LeukemiaWho this might be right forLeukaemia, Lymphocytic, Chronic Novartis Pharmaceuticals 447
Large-scale testing (Phase 3)Study completedNCT02053610What this trial is testingCLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)Who this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 787
Testing effectiveness (Phase 2)Study completedNCT00049413What this trial is testingCombination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaWho this might be right forLeukemiaLymphoma Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)Study completedNCT02005289What this trial is testingPhase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLLWho this might be right forContiguous Stage II Small Lymphocytic LymphomaNoncontiguous Stage II Small Lymphocytic LymphomaProlymphocytic Leukemia+9 more Ohio State University Comprehensive Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT03010358What this trial is testingEntospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin LymphomaWho this might be right forAnemiaB-Cell Prolymphocytic LeukemiaGrade 1 Follicular Lymphoma+11 more Alexey Danilov, MD 24
Large-scale testing (Phase 3)Ended earlyNCT01732926What this trial is testingEfficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin LymphomasWho this might be right forIndolent Non-Hodgkin's Lymphomas Gilead Sciences 475
Early research (Phase 1)Ended earlyNCT00019708What this trial is testingGeldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNon-Hodgkin Lymphoma+25 more National Cancer Institute (NCI) 45
Early research (Phase 1)Ended earlyNCT00543114What this trial is testingDose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia Dana-Farber Cancer Institute 9
Early research (Phase 1)Study completedNCT00734890What this trial is testingVandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+2 more National Institutes of Health Clinical Center (CC) 18
Post-approval studies (Phase 4)Looking for participantsNCT06876649What this trial is testingA Master Protocol to Evaluate the Long-Term Safety of (LY3527727) PirtobrutinibWho this might be right forChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma Eli Lilly and Company 787
Large-scale testing (Phase 3)Study completedNCT01951885What this trial is testingTac, Mini-MTX, MMF Versus Tac, MTX for GVHD PreventionWho this might be right forChronic Myelogenous LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+7 more Case Comprehensive Cancer Center 101